In this Oncology Brothers podcast episode, Naval Daver, MD, MD Anderson Cancer Center, Houston, Texas, discusses treatment strategies for both therapy‑related and de novo acute myeloid leukemia (AML), focusing on cases…
Tara Lin, MD, University of Kansas Medical Center, Kansas City, Kansas, discusses how she approaches choosing induction therapy for patients with treatment-related acute myeloid leukemia, emphasizing that fitness…
NEW YORK (Reuters Health) – New research indicates that the outcomes of localized prostate cancer following conservative management have improved in the last few decades. According to the…
NEW YORK (Reuters Health) – When patients who need coronary artery bypass grafts or an aortic valve have significant carotid stenosis, some surgeons combine the cardiac surgery with…
NEW YORK (Reuters Health) – Biomarkers of endothelial dysfunction are elevated in premenopausal women with migraine, which may help to explain the link between migraine and strokes, according…
NEW YORK (Reuters Health) – Although dimenhydrinate can reduce vomiting in children with acute gastroenteritis, it does not improve oral rehydration or clinical outcomes, according to a report…
NEW YORK (Reuters Health) – Darusentan, a selective endothelin-receptor blocker, can reduce blood pressure in patients who have not reached their target levels using three or more antihypertensive…
NEW YORK (Reuters Health) – Perioperative corticosteroids reduce the risk of postoperative atrial fibrillation (AF) by more than 50% in patients undergoing cardiac surgery, according to a meta-analysis…
NEW YORK (Reuters Health) – Particle beam radiation has been available since 1954, but a systematic literature review has failed to turn up statistically or clinically significant differences…
NEW YORK (Reuters Health) – New guidelines issued jointly by the American Academy of Neurology and the Child Neurology Society point out that children with microcephaly are at…
NEW YORK (Reuters Health) – Findings from a systematic review indicate that while tamoxifen, raloxifene, and tibolone all reduce the risk of primary breast cancer, the drugs differ…
NEW YORK (Reuters Health) – A dexamethasone-based protocol can cut the risk of relapse and improve survival in high-risk children with acute lymphoblastic leukemia (ALL), with fewer side…
